Search Results 351-360 of 20509 for hepatitis

  1. Testing The Use Of Ado-Trastuzumab Emtansine Compared To The Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) For Recurrent, Metastatic, Or Unresectable HER2-Positive Salivary Gland Cancer - Mayo Clinic

    immune to hepatitis B (anti-Hepatitis B surface antibody positive) are eligible (e.g., patients immunized against hepatitis B) - For patients with a known ...

  2. Fatty liver disease (MASLD) - Doctors and departments - Mayo Clinic

    mary sclerosing cholangitis, Autoimmune hepatitis, Alcoholic hepatitis. Show more areas of focus for Elizabeth J. Carey, M.D.. David ...

  3. Medical Research & Education - Mayo Clinic News Network

    ... hepatitis. Jay Furst. February 15, 2022. Research. Regenerative Medicine Minnesota awards 5 research grants to Mayo Clinic. Mayo Clinic Staff. February 15, 2022.

  4. Milk thistle - Mayo Clinic

    Research on the effects of milk thistle on liver disease, such as cirrhosis and hepatitis C, has shown mixed results. Our take. Generally safe. Milk thistle ...

  5. Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma - Mayo Clinic

    can be enrolled if a confirmatory negative hepatitis C RNA test is obtained - Is seropositive for hepatitis B (defined by a positive test for hepatitis B ...

  6. Mayo Clinic Transplant Center - Doctors

    ... Hepatitis C, Hepati...tis B, Hepatocellular carcinoma, Primary biliary cholangitis, Nonalcoholic fatty liver disease, Cirrhosis, Jaundice, Alcoholic hepatitis ...

  7. Transplant Medicine Calculators - Medical Professionals - Mayo Clinic

    MELD Score and 90-Day Mortality Rate for Alcoholic Hepatitis · Medical Professionals ...

  8. MELD calculator - Medical Professionals - Mayo Clinic

    Hepatitis C livers now usable for transplant into patients uninfected with hepatitis C. ITT-20434705. Medical Professionals; MELD calculator. 3X your impact ...

  9. Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas - Mayo Clinic

    Participation eligibility · Patients with a positive hepatitis B core antibody but with negative hepatitis B DNA may participate, but must have hepatitis ...

  10. HIV/AIDS - Symptoms and causes - Mayo Clinic

    If you have hepatitis B, you should see an infectious disease or liver specialist before beginning PrEP therapy. Use treatment as prevention, also called TasP.